Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

@inproceedings{MartinLiberal2013ClinicalAA,
  title={Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma},
  author={Juan Martin-Liberal and Salma Moona Alam and Anastasia Constantinidou and Cyril Fisher and Komel Khabra and Christina Messiou and David R Olmos and Scott J. Mitchell and Omar Al-Muderis and Aisha B. Miah and Mark Linch and Robin L Jones and Michelle Scurr and Ian Judson and Charlotte Benson},
  booktitle={Sarcoma},
  year={2013}
}
Background. Soft-tissue sarcomas (STS) are a heterogeneous group of diseases with lack of effective treatments in most cases. Previous data suggest that continuous infusional ifosfamide regimens might improve cytotoxicity and tolerability compared to standard schedules. Methods. We retrospectively report the outcome of 35 patients affected by STS treated with a 14-day infusional ifosfamide regimen (1000 mg/m(2)/day) in our institution. Predictive factors for toxicity were also explored. Results… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Clinical and molecular approaches towell differentiated and dedifferentiated liposarcoma

  • S. Singer
  • Current Opinion in Oncology
  • 2011

Ifosfamide re-challenge in soft-tissue sarcoma

  • A. Constantinidou, R. L. Jones
  • Proceedings of the 16th Annual Meeting Connective…
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…